Supplementary Figure S3 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplementary Figure S3 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC2024
2. 2Supplementary Figure S4 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC2024
3. 3Supplementary Figure S4 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC2024
4. 4Supplementary Figure S9 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC2024
5. 5Supplementary Figure S9 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC2024